- Raised $800k funding round, Jan 2020
About
Chronic, non-healing wounds impact millions, generating overall cost projections exceeding $100 billion, including costs for infection management, among which surgical wounds and diabetic ulcers were the most expensive to treat.
Wound healing is a complex, dynamic cellular-based process supported by a myriad of cellular events that must be tightly coordinated to efficiently repair damaged tissue. Electric fields at wounds play a major role in wound healing and regenerative processes, with possible mechanisms involving regulation of cell migration, cell differentiation, and tissue growth.
NTMed is developing the first and only materials combining: Electrical exogenous stimulus enhancing healing processes, Best antimicrobial efficacy, and highest safety profile.
Funding history · 1 round · $800K total
Q&A
- What is NTMed's primary focus?
- NTMed is developing materials that combine electrical exogenous stimulus, antimicrobial efficacy, and a high safety profile to enhance wound healing processes.
- When was NTMed founded?
- NTMed was founded in January 2020.
- What is the total amount of funding NTMed has raised to date?
- NTMed has raised a total of $800,000 USD.
- What is NTMed's primary sector classification?
- NTMed's primary sector is Health Tech & Life Sciences.
- What business models does NTMed utilize?
- NTMed utilizes a B2B2C business model.
- What is the product stage of NTMed's offerings?
- NTMed's products are currently in the R&D stage.
Team · 3
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/93257951 |
Identifiers & details
| Founded | 2020-1 |
|---|---|
| Employees (exact) | 4 |